ChromaDex News - CDXC

Company Name	Stock Ticker Symbol	Market	Type
ChromaDex Corporation	CDXC	NASDAQ	Common Stock

	Price Change	Change Percent	Stock Price	Last Traded
	0.085	2.51%	3.475	11:14:30

Open Price	Low Price	High Price	Close Price	Prev Close
3.44	3.38	3.52		3.39

more quote information »

Recent News

Date	Time	Source	Heading
4/25/2024	08:34	BW	ChromaDex Announces Nationwide Launch of Tru Niagen® at The..
4/24/2024	08:34	BW	ChromaDex to Report First Quarter 2024 Financial Results on..
4/23/2024	08:32	BW	ChromaDex Announces Inaugural Major Grocery Debut of Tru..
3/26/2024	08:32	BW	ChromaDex Announces Tru Niagen® is Now Third-Party Verified..
3/06/2024	16:04	BW	ChromaDex Corporation Reports Fourth Quarter and Fiscal Year..
3/06/2024	16:02	EDGAR2	Form 8-K - Current report
3/06/2024	16:01	EDGAR2	Form 10-K - Annual report [Section 13 and 15(d), not S-K..
2/23/2024	21:00	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2/23/2024	20:59	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2/21/2024	08:32	BW	ChromaDex to Report Fourth Quarter 2023 Financial Results on..
2/05/2024	08:32	BW	ChromaDex to Participate in Renmark’s Virtual Non-Deal..
1/26/2024	16:08	BW	ChromaDex to Present at the Lytham Partners 2024 Investor..
12/20/2023	09:04	BW	ChromaDex Supports the US Military with its Industry Leading..
12/13/2023	16:00	EDGAR2	Form 8-K - Current report
12/12/2023	10:30	PRNUS	Neurohacker Collective and ChromaDex Partner to Optimize..
12/04/2023	16:12	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
11/30/2023	08:34	BW	A Milestone Phase I Randomized, Double-Blind Clinical Trial..
11/15/2023	08:32	BW	Newly Published Phase II Clinical Study Demonstrates that..
11/09/2023	08:32	BW	ChromaDex to Participate in Renmark’s Virtual Non-Deal..
11/08/2023	16:02	EDGAR2	Form 8-K - Current report
11/08/2023	16:02	BW	ChromaDex Corporation Reports Third Quarter 2023 Financial..
11/08/2023	16:01	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/01/2023	08:34	BW	ChromaDex Debuts Clinical Strength Tru Niagen® Pro 1,000mg..
10/31/2023	08:34	BW	ChromaDex to Report Third Quarter 2023 Financial Results on..
10/26/2023	08:32	BW	ChromaDex and Zesty Paws® Crack the Code on Cellular Health..
10/02/2023	08:32	BW	A Milestone Clinical Study Reveals that Elevating..
9/07/2023	06:23	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
9/07/2023	06:20	EDGAR2	Form SC 13D/A - General statement of acquisition of..
8/24/2023	08:32	BW	Preclinical Study Builds on Growing Body of Evidence..
8/15/2023	21:11	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
8/09/2023	16:02	EDGAR2	Form 8-K - Current report
8/09/2023	16:02	BW	ChromaDex Corporation Reports Second Quarter 2023 Financial..
8/09/2023	16:01	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/08/2023	08:34	BW	ChromaDex Launches Tru Niagen® with iHerb, the World’s..
8/07/2023	08:32	BW	ChromaDex to Participate in Renmark’s Virtual Non-Deal..
8/02/2023	08:02	BW	ChromaDex to Report Second Quarter 2023 Financial Results on..
7/18/2023	08:32	BW	Findings from Published Abstracts Showcase the Importance of..
7/06/2023	16:30	EDGAR2	Form 424B5 - Prospectus [Rule 424(b)(5)]
7/06/2023	00:15	EDGAR2	Form EFFECT - Notice of Effectiveness
6/16/2023	08:32	BW	ChromaDex, a Global Authority on Nicotinamide Adenine..
5/30/2023	08:34	BW	ChromaDex to Participate in the LD Micro Invitational XIII
5/11/2023	08:34	BW	ChromaDex to Present at the Lytham Partners Spring 2023..
5/10/2023	16:02	BW	ChromaDex Corporation Reports First Quarter 2023 Financial..
5/02/2023	08:32	BW	ChromaDex to Report First Quarter 2023 Financial Results on..